We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Carducci

Michael A. Carducci MD, FACP, FASCO

AEGON Professor in Prostate Cancer Research, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Dr. Carducci is the AEGON Professor in Prostate Cancer Research and the Associate Director for Clinical Research at the Hopkins Kimmel Cancer Center. He is the Oncology Research Director for the National Capital Region. His lab and clinical research focus is on the evaluation of new therapies for urologic cancers, primarily prostate and renal cancer.  Dr. Carducci has received the Michaele Christian Award for Oncology Drug Development. He is a member of the Miller-Coulson Academy of Clinical Excellence.  He is the Chair of the GU Oncology Committee of ECOG-ACRIN, a member of the GU Steering Committee, and the Investigational Drug Steering Committee for the NCI, as well as the Associate Editor for GU Cancers for the Journal of Clinical Oncology.   

Disclosures

Dr. Carducci reports the following:
  • Paid Consultant: Pfizer, Foundation Medicine, Roche Genentech, Exelexis
  • Clinical Research: Pfizer, EMD Serrano, Merck, Arcus, Astra-Zeneca

Recent Contributions to PracticeUpdate:

  1. Active Surveillance of Metastatic Renal Cell Carcinoma